Semax + Selank + Pinealon

What Is the Semax, Selank, and Pinealon Combination?

Semax is a synthetic peptide developed from a fragment of ACTH, modified to retain effects on the nervous system while removing the hormone's cortisol-releasing activity. It is studied primarily for stroke recovery and neuroprotection. Selank is a synthetic peptide developed from tuftsin, a naturally occurring immune-related peptide, and is studied primarily for calming and anxiety-related effects. Both are approved as prescription medications in Russia and share a development history at the Institute of Molecular Genetics of the Russian Academy of Sciences.

Pinealon comes from the Khavinson bioregulator research program, which also produced Epithalon and Thymalin. It is a short tripeptide studied for protecting brain cells against oxidative stress. Semax and Selank each have identifiable clinical trial data, while Pinealon's evidence comes almost entirely from one research group with much less independent replication.

What This Combination Is Being Researched For

• Neuroprotection and Stroke Recovery

  Semax's research base centers on stroke recovery, with clinical evidence examining neurological outcomes when added to standard treatment and a proposed mechanism involving increased BDNF levels.^[1][2]

• Anxiety Reduction

  Selank's research base centers on anxiolytic effects, with a Russian clinical trial comparing it with a standard anxiolytic medication and also examining fatigue-related outcomes.^[3]

• Oxidative Stress Protection

  Pinealon has been studied for reducing oxidative damage in brain cell cultures, with animal research extending into models of prenatal oxidative stress. This research base is narrow and concentrated within one research group.^[4]

How the Combination Works

• Semax's Role

  Research points to Semax increasing brain-derived neurotrophic factor levels in relevant brain regions without triggering the cortisol-releasing activity of full-length ACTH, the proposed basis for its neuroprotective research.^[2]

• Selank's Role

  Research points to Selank slowing the breakdown of the body's enkephalin signaling molecules while influencing GABA, serotonin, and dopamine systems, proposed to underlie its calming effects.^[3]

• Pinealon's Role

  Research points to Pinealon reducing reactive oxygen species in brain cells exposed to oxidative stress, with researchers also proposing that the tripeptide may interact with gene activity.^[4]

• Why the Three Are Paired

  The research-community rationale combines Semax's neuroprotective focus, Selank's anxiety-related focus, and Pinealon's oxidative-stress research. No published study has tested the three-peptide combination itself.

Reconstitution and Handling

All three peptides are typically supplied as lyophilized powder in sealed vials and reconstituted with bacteriostatic water in research settings. Water should be added slowly rather than injected directly into the powder, and vials should be swirled rather than shaken.

Because the amount of water affects the final concentration, each peptide should be calculated separately before mixing. Once reconstituted, the solutions are generally kept refrigerated to help preserve stability.

Key Takeaways

This combination pairs Semax and Selank, two peptides with genuine if geographically concentrated clinical research histories, with Pinealon, whose evidence is thinner and less independently replicated. The three have not been studied together, so the combination should be understood as a research-community pairing based on complementary proposed roles rather than evidence from combined-use trials.

Frequently Asked Questions

Sources and Research

1. Gusev EI, Skvortsova VI, Miasoedov NF, et al. Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study). Zh Nevrol Psikhiatr Im S S Korsakova. 1997;97(6):26-34.
2. Dolotov OV, Karpenko EA, Seredenina TS, et al. Semax, an analogue of adrenocorticotropin(4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. J Neurochem. 2006;97(Suppl 1):82-86.
3. Zozulya AA, Neznamov GG, Siuniakov TS, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48.
4. Khavinson V, Ribakova Y, Kulebiakin K, Vladychenskaya E, Kozina L, Arutjunyan A, Boldyrev A. Pinealon Increases Cell Viability by Suppression of Free Radical Levels and Activating Proliferative Processes. Rejuvenation Res. 2011;14(5):551-558.